Back to Search
Start Over
Acneiform skin lesions associated with cetuximab therapy: Report of two cases
- Publication Year :
- 2010
-
Abstract
- Cetuximab, is an IgG1 chimeric monoclonal antibody type of epidermal growth factor receptor (EGFR). It is most commonly prescribed for metastatic colorectal cancer, administered alone or in combination with irinotecan-based chemotherapy regimens (Lee et al., 2008; Segaert et al., 2005; Segaert and Cutsem 2005; Scope et al., 2009). Acneiform eruption is the most common adverse effect with 80% of incidence (Segaert and Cutsem 2005; Lee et al., 2008). We report two cases of severe acneiform eruption induced by cetuximab with metastatic colorectal cancer. © 2010 OMU All rights reserved.
- Subjects :
- Acneiform eruption
Cetuximab
Chemotherapy
Side effect
Irinotecan
Colorectal cancer
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.od......9773..ae27b23f0693b1518be5ca18e5743b5a